SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Feb 11, 2019

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Feb. 11, 2019 · CIK: 0001711786 · Accession: 0001615774-19-002259

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-227772

Date
February 11, 2019
Author
(UK) Ltd.
Form
CORRESP
Company
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)

Letter

Re: Hoth Therapeutics, Inc.

February 11, 2019

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, DC 20549

Registration Statement on Form S-1 (File No. 333-227772)

Concurrence in Withdrawal Request

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on February 6, 2019, in which we, Laidlaw & Company (UK) Ltd., as representative of the underwriters of the offering, joined Hoth Therapeutics, Inc.’s (the “Company’s”) request for acceleration of the effective date of the above-referenced Registration Statement. The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Sincerely,
Laidlaw & Company
(UK) Ltd.

Show Raw Text
CORRESP
1
filename1.htm

February 11, 2019

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, DC 20549

Re:    Hoth Therapeutics,
Inc.

Registration Statement on Form S-1 (File No. 333-227772)

Concurrence in Withdrawal Request

Ladies and Gentlemen:

Reference is made to our
letter, filed as correspondence via EDGAR on February 6, 2019, in which we,  Laidlaw
& Company (UK) Ltd., as representative of the underwriters of the offering, joined Hoth
Therapeutics, Inc.’s (the “Company’s”) request for acceleration of the effective date of the above-referenced
Registration Statement. The Company is no longer requesting that such Registration Statement be declared effective at this time
and we hereby formally withdraw our request for acceleration of the effective date.

Sincerely,

Laidlaw & Company
(UK) Ltd.

By: /s/
                              Hugh Regan

  Name:
                  Hugh Regan

  Title:
                    Executive Director

     -1-